China approves PFE-marketed GLP-1 for weight loss: https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-ecnoglutide-injection-approved-by-chinas-national-medical-products-administration-nmpa-for-chronic-weight-management-302706442.html PFE licensed the commercial rights in China from Sciwind two weeks ago (#msg-177329896).